... injections weekly this past year. He is becoming more and more anemic so now they want to switch to Vidaza... any thoughts?
The standard care for patients with myelodysplastic syndrome (MDS) and decreased blood counts is constantly changing. Supportive therapy, including transfusions of the cells that are missing (ie, RBCs, platelets), and treatment of infections are the main treatments. New drugs such as 5-azacytidine (azacytidine [Vidaza]),11,12 5-aza-2-deoxycytidine (decitabine [Dacogen]), and lenalidomide (Revlimid)13 are now approved by the US Food and Drug Administration for myelodysplastic syndrome (MDS)
See this link for more information.
Search for questions
Still looking for answers? Try searching for what you seek or ask your own question.
Updated 18 Dec 2009 • 1 answer
Updated 23 Feb 2014 • 1 answer
Updated 3 Jun 2015 • 1 answer
Updated 25 Nov 2014 • 1 answer
Updated 18 Mar 2016 • 1 answer